Clinical Trial Update: Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating minocycline for postsurgical symptom reduction in head and neck cancer was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Head And Neck Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-10-18